Insider · CIK 0001261262

LINK GORDON H JR

Reports to the SEC for 2 companies · AMES, IA

sec.gov

Transactions

Companies

Filings

CIK

0001261262

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2014-10-24	LUMOS PHARMA, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+2,500 sh	$2.10	+$5,250	16,913
2014-10-24	LUMOS PHARMA, INC.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−2,500 sh	—	—	53,739
2014-10-24	LUMOS PHARMA, INC.S Sale	Chief Financial Officer	SSale	−2,500 sh	$40.39	−$101K	14,413
2014-02-24	LUMOS PHARMA, INC.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−8,500 sh	—	—	56,239
2014-02-24	LUMOS PHARMA, INC.S Sale	Chief Financial Officer	SSale	−8,500 sh	$50.00	−$425K	16,313
2014-02-24	LUMOS PHARMA, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+8,500 sh	$2.10	+$17.9K	24,813
2014-02-04	LUMOS PHARMA, INC.S Sale	Chief Financial Officer	SSale	−400 sh	$36.74	−$14.7K	16,413
2014-02-04	LUMOS PHARMA, INC.S Sale	Chief Financial Officer	SSale	−100 sh	$37.44	−$3,744	16,313
2014-02-04	LUMOS PHARMA, INC.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−500 sh	—	—	64,739
2014-02-04	LUMOS PHARMA, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+500 sh	$2.10	+$1,050	16,813
2014-01-07	LUMOS PHARMA, INC.S Sale	Chief Financial Officer	SSale	−453 sh	$22.55	−$10.2K	14,213
2014-01-07	LUMOS PHARMA, INC.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−500 sh	—	—	65,239
2014-01-07	LUMOS PHARMA, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+500 sh	$2.10	+$1,050	14,713
2014-01-07	LUMOS PHARMA, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−47 sh	$22.55	−$1,059.803	14,666
2014-01-02	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+27K sh	—	—	27,000
2014-01-02	LUMOS PHARMA, INC.A Award	Chief Financial Officer	AAward	+5,700 sh	—	—	14,213
2013-12-03	LUMOS PHARMA, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−51 sh	$20.96	−$1,068.858	6,862
2013-12-03	LUMOS PHARMA, INC.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−500 sh	—	—	65,739
2013-12-03	LUMOS PHARMA, INC.S Sale	Chief Financial Officer	SSale	−449 sh	$20.96	−$9,410.142	6,413
2013-12-03	LUMOS PHARMA, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+500 sh	$2.10	+$1,050	6,913
2013-06-10	LUMOS PHARMA, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+10.5K sh	$2.10	+$22.1K	16,913
2013-06-10	LUMOS PHARMA, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−1,103 sh	$20.00	−$22.1K	15,810
2013-06-10	LUMOS PHARMA, INC.S Sale	Chief Financial Officer	SSale	−9,397 sh	$20.00	−$188K	6,413
2013-06-10	LUMOS PHARMA, INC.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−10.5K sh	$2.10	−$22.1K	66,239
2013-05-23	LUMOS PHARMA, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−108 sh	$15.67	−$1,692.36	7,105
2013-05-23	LUMOS PHARMA, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+800 sh	$2.10	+$1,680	7,213
2013-05-23	LUMOS PHARMA, INC.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−800 sh	$2.10	−$1,680	76,739
2013-05-23	LUMOS PHARMA, INC.S Sale	Chief Financial Officer	SSale	−692 sh	$15.67	−$10.8K	6,413
2013-05-09	LUMOS PHARMA, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−459 sh	$14.65	−$6,724.35	9,154
2013-05-09	LUMOS PHARMA, INC.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−3,200 sh	$2.10	−$6,720	77,539
2013-05-09	LUMOS PHARMA, INC.S Sale	Chief Financial Officer	SSale	−2,741 sh	$14.65	−$40.2K	6,413
2013-05-09	LUMOS PHARMA, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+3,200 sh	$2.10	+$6,720	9,613
2013-01-14	LUMOS PHARMA, INC.Option to Purchase Common StockA Award	Chief Financial Officer	AAward	+36K sh	—	—	36,000
2013-01-03	LUMOS PHARMA, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+1,000 sh	$2.10	+$2,100	5,313
2013-01-03	LUMOS PHARMA, INC.Stock Option (Right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−1,000 sh	—	—	80,739
2013-01-03	LUMOS PHARMA, INC.S Sale	Chief Financial Officer	SSale	−826 sh	$12.10	−$9,992.948	4,313
2013-01-03	LUMOS PHARMA, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−174 sh	$12.10	−$2,105.052	5,139
2012-11-29	LUMOS PHARMA, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−168 sh	$12.53	−$2,104.435	5,145
2012-11-29	LUMOS PHARMA, INC.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−1,000 sh	—	—	81,739
2012-11-29	LUMOS PHARMA, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+1,000 sh	$2.10	+$2,100	5,313
2012-11-29	LUMOS PHARMA, INC.S Sale	Chief Financial Officer	SSale	−832 sh	$12.53	−$10.4K	4,313
2012-11-01	LUMOS PHARMA, INC.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−1,000 sh	—	—	82,739
2012-11-01	LUMOS PHARMA, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+1,000 sh	$2.10	+$2,100	5,313
2012-11-01	LUMOS PHARMA, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−153 sh	$13.77	−$2,106.366	5,160
2012-11-01	LUMOS PHARMA, INC.S Sale	Chief Financial Officer	SSale	−847 sh	$13.77	−$11.7K	4,313
2012-10-15	LUMOS PHARMA, INC.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−5,500 sh	—	—	0
2012-10-15	LUMOS PHARMA, INC.S Sale	Chief Financial Officer	SSale	−4,721 sh	$14.84	−$70.1K	4,313
2012-10-15	LUMOS PHARMA, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−779 sh	$14.84	−$11.6K	9,034
2012-10-15	LUMOS PHARMA, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+5,500 sh	$2.10	+$11.6K	9,813
2012-06-21	LUMOS PHARMA, INC.Stock Option (Right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+3,500 sh	—	—	0

Recent filings

Accepted (ET)
Oct 284
NEWLINK GENETICS CORP0001126234-14-000177
SEC(opens sec.gov)
Feb 264
NEWLINK GENETICS CORP0001126234-14-000070
SEC(opens sec.gov)
Feb 64
NEWLINK GENETICS CORP0001126234-14-000060
SEC(opens sec.gov)
Jan 94
NEWLINK GENETICS CORP0001126234-14-000034
SEC(opens sec.gov)
Jan 64
NEWLINK GENETICS CORP0001126234-14-000026
SEC(opens sec.gov)
Dec 54
NEWLINK GENETICS CORP0001126234-13-000157
SEC(opens sec.gov)

Companies

Address

C/O NEWLINK GENETICS CORPORATION 2503 SOUTH LOOP DR., SUITE 5100

AMES, IA, 50010